News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Bristol-Myers Squibb (BMY) And Pfizer (PFE) To Highlight Commitment To Reducing The Risk Of Stroke Caused By Non-Valvular Atrial Fibrillation (NVAF) And Treating Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) At ESC Congress 2017 8/18/2017
J.A.R. Laboratories Release: New Study Results Show Over-the-Counter LidoPatch As Effective As Prescription Lidocaine Patches 8/15/2017
Amarin (AMRN)'s REDUCE-IT Cardiovascular Outcomes Study Of Vascepa To Continue As Planned At Recommendation Of Independent Data Monitoring Committee 8/14/2017
Symbiomix Presents New Data On Solosec 8/10/2017
PharmaMar Starts A Quadruple Combination Study With Aplidin For The Treatment Of Multiple Myeloma 8/9/2017
Cytovia, Inc. (MAXM), Immune Pharma’s Oncology Subsidiary, Announces The Publication Of New Results In The British Journal Of Haematology And Filing Of A World-Wide Patent Protecting The Use Of Ceplene In Chronic Myeloid Leukemia (CML) 8/7/2017
Department Of Defense Report Shows Bach Pharma Drug Gvt Reverses Brain Dysfunction 8/2/2017
Mallinckrodt (MNK) Enrolls First Patient In Phase IV Registry Of INOMAX (Nitric Oxide) Gas For Inhalation For Pulmonary Hypertension In Neonates 8/1/2017
Diem Labs Release: Citicoline In Cerenx Crosses Blood-Brain Barrier For Brain Cell Recovery After Stroke Attack 8/1/2017
Alcresta Announces Positive Results, Relizorb Increased Fat Absorption In Both Adult And Pediatric Patients With Cystic Fibrosis Receiving Enteral Nutrition 7/31/2017
Large Study Shows Natera’s Panorama Prenatal Screen To Be Highly Accurate In Identifying DNA Microdeletions Associated With Serious Health Implications 7/31/2017
Boehringer Ingelheim Starts Clinical Study On Interchangeability Between Its Adalimumab Biosimilar Candidate And HUMIRA 7/27/2017
Aratana (PETX) Announces Positive Results For AT-003 7/26/2017
Neurana Pharma Initiates Study To Assess The Non-Sedating Properties Of Tolperisone Among Healthy Volunteers 7/26/2017
Pacira (PCRX) Announces Publication Of Phase IV Study Of EXPAREL In Patients Undergoing Total Knee Replacement In The Journal Of Arthroplasty 7/26/2017
ViiV Healthcare Announces Superior Efficacy Of Dolutegravir Versus Lopinavir/Ritonavir In Second-Line HIV Treatment In Resource-Limited Settings 7/25/2017
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA (C1 Esterase Inhibitor Subcutaneous [Human]) 7/21/2017
Medtronic (MDT) Release: Five-Year Data Demonstrate Interstim Therapy Offers Sustained Long-Term Efficacy And Quality Of Life Improvements For Overactive Bladder Patients 7/17/2017
Symbiomix Announces Publication Of Pivotal Data For Investigational Solosec For The Treatment Of Bacterial Vaginosis 7/17/2017
KaloBios (KBIO) Receives Orphan Drug Designation For Benznidazole In The Treatment Of Chagas Disease 7/12/2017
Lipogems Release: New Prospective, Randomized Controlled Study Compares The Safety And Performance Of A Next Generation Adipose Tissue Technology (Lipogems) Vs. Platelet Rich Plasma In Patients With Knee Osteoarthritis 7/11/2017
CSL Behring Release: New Findings Show AFSTYLA Provides Long-Lasting Efficacy Without Increased Product Consumption For Prophylactic And On-Demand Treatment Of Hemophilia A 7/10/2017
Elite Pharma (ELI) Reports Topline Results From A Pivotal Fed Bioequivalence Study For SequestOx 7/10/2017
ALK - Five-year GRAZAX Asthma Prevention (GAP) Trial Reveals Benefits Of Early Treatment Intervention In Children 7/7/2017
Immune Pharma's Oncology Subsidiary, Cytovia, Inc. (MAXM), Announces Additional Clinical Trial Results On The Efficacy Of Ceplene In Combination With Low-Dose IL-2 In Patients With Acute Myeloid Leukemia, Recently Published In Leukemia, A Leading Hematology Journal 7/5/2017
ALK: Five-year GRAZAX Asthma Prevention (GAP) Trial Reveals Benefits Of Early Treatment Intervention In Children 7/5/2017
Minomic Clinical Study Progresses For Miltuximabtm In Prostate, Bladder, And Pancreatic Cancer 6/29/2017
Bayer (BAY) Now Enrolling Patients Into A Global Pulmonary Arterial Hypertension Study 6/29/2017
PerkinElmer (PKI) Release: Groundbreaking Multi-Center Clinical Trial Confirms Low-Dose Aspirin Therapy Reduces Rate Of Pre-Term Preeclampsia 6/28/2017
Neovii Pharma: Long-Term Outcomes After Standard Graft-Versus-Host Disease (GvHD) Prophylaxis In Hemopoietic Cell Transplantation From Matched Unrelated Donors Strongly Support The Use Of Grafalon (Anti-Human-T-Lymphocyte Immunoglobulin) As Standard Therapy 6/26/2017
Novartis AG (NVS) Pivotal CTL019 6-Month Follow-Up Data Show Durable Remission Rates In Children, Young Adults With R/R B-Cell ALL 6/23/2017
Eisai Inc. (ESALF.PK) Announces Lorcaserin HCl CAMELLIA-TIMI 61 Study Will Continue As Planned Based On Interim Safety Analysis By Independent Data Monitoring Committee (DMC) 6/21/2017
Eli Lilly (LLY) Release: New Safety And Long-Term Efficacy Data From Baricitinib Clinical Trials In Patients With Moderate-To-Severe Rheumatoid Arthritis Presented At EULAR 2017 6/16/2017
Pfizer (PFE) Announces Results From XELJANZ (Tofacitinib Citrate) ORAL Strategy Study Published In The Lancet And Presented At The EULAR Annual Congress 6/16/2017
ResQ Pharma Receives FDA Orphan Drug Designation For Lipidrescue Therapy For The Treatment Of Local Anesthetic Systemic Toxicity 6/16/2017
BioTime (BTX)’s Renevia Achieves Primary Endpoint In European Pivotal Trial 6/14/2017
Eli Lilly (LLY) Release: Jardiance (empagliflozin) Analysis Reinforces Established Safety Profile 6/14/2017
Sorrento (SRNE)' Pain Subsidiary, Scilex, Announces Positive Data From Head To Head Adhesion Study With Its Lead Product, ZTlido 6/14/2017
Janssen Pharmaceutical Release: INVOKANA (canagliflozin) Significantly Reduces The Combined Risk Of Cardiovascular Death, Myocardial Infarction And Stroke In The CANVAS Program 6/13/2017
American Diabetes Association Release: Autoantigen GAD-Vaccine Is Safe For Children At High Risk For Developing Type 1 Diabetes 6/13/2017
Novo Nordisk A/S (NVO) Release: Tresiba Demonstrated No Increased Risk Of Major Cardiovascular Events And Significant Reduction In Rates Of Severe Hypoglycaemia Compared To Insulin Glargine U100 In The DEVOTE Trial 6/13/2017
Mylan (MYL) And BioCon (BIOCON.NS) Present Clinical Data On Insulin Glargine At The American Diabetes Association's 77th Scientific Sessions 6/12/2017
New Analysis Shows Sanofi (SNY)'s Soliqua 100/33 Lowered HbA1c by More Than 2 Percent In Patients With Screening Levels Greater Than 9 Percent 6/12/2017
Regeneron (REGN) And Sanofi (SNY) Announce Positive Results From First Dedicated Studies Evaluating Praluent (Alirocumab) In Individuals With Diabetes And Hypercholesterolemia 6/12/2017
In Senior Adults Treated With Basal Insulin, Switching To Sanofi (SNY)'s Toujeo Halved Hypoglycemia Risk 6/12/2017
Amarin (AMRN) Release: Vascepa (Icosapent Ethyl) Showed Reductions In Potentially Atherogenic Lipid Parameters In Statin-Treated Women With Type 2 Diabetes And Persistent High Triglycerides 6/12/2017
Scientifically Advanced Delivery Technology In Sleep Management Debuts At SLEEP 2017 With Clinical Data Showing REMfresh®, The First And Only Continuous Release And Absorption Melatonin, Helps Maintain Sleep For Up To 7 Hours 6/12/2017
Sirtex Medical (SRX.AX) Release: SIR-Spheres Y-90 Resin Microspheres Showed No Significant Difference In Overall Survival (OS) Compared To Sorafenib In Advanced HCC With Significantly Fewer Severe Adverse Events, New Asia-Pacific Study Finds 6/6/2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up 6/5/2017
AbbVie (ABBV) Release: New Data Presented At ASCO 2017 Finds IMBRUVICA (Ibrutinib) May Offer A More Targeted Approach To Chronic Lymphocytic Leukemia (CLL) Treatment Than Chemotherapy Agent Chlorambucil In Treatment-Naïve Patients 6/5/2017
Shionogi Release: Further Evidence Supports Cefiderocol Activity Against MDR Gram-Negative Pathogens: Data Presented At The American Society For Microbiology Microbe (ASM) Meeting 6/1/2017
EMD Serono To Present Data Highlighting Investigational Cladribine Tablets At CMSC 2017 5/25/2017
Adaptimmune (ADAP) Announces Initiation Of Study To Evaluate SPEAR T-Cell Therapy Targeting NY-ESO In Combination With KEYTRUDA (Pembrolizumab) In Multiple Myeloma 5/25/2017
PTC Therapeutics (PTCT) Release: New Analysis Of ACT DMD Placebo Data On Corticosteroids Presented At International Society For Pharmacoeconomics And Outcomes Research 22nd Annual International Meeting 5/24/2017
First Patient Enrolled In Mallinckrodt (MNK) Phase IV Trial Of H.P. Acthar Gel (Repository Corticotropin Injection) For Multiple Sclerosis Relapse 5/24/2017
Torax Medical Release: LINX More Effective Than Omeprazole At Controlling Regurgitation And Improving Quality Of Life In Patients With Gastroesophageal Reflux Disease (GERD) 5/24/2017
Amgen (AMGN) Release: Repatha (Evolocumab) Reduced Cardiovascular Events In Patients With Baseline LDL-C Levels Below Current Targets 5/22/2017
Salix (SLXP) Announces The Publication Of A Study Evaluating The Safety And Efficacy Of UCERIS (Budesonide) Tablets For Induction Of Remission In Patients With Active Mild To Moderate Ulcerative Colitis Refractory To Mesalamine Therapy 5/18/2017
Plandai Biotechnology, Inc. (PLPL.OB) Announces Phytofare To Be Focus Of Human Clinical Trial For Type II Diabetes In Mauritius 5/18/2017
Cinfa Biotech S.L. Announces Positive Top-Line Data From Second Clinical Study With Pegfilgrastim Biosimilar Candidate B12019 5/17/2017
FDA Grants Octapharma USA Orphan Drug Designation For Octagam10% For The Treatment Of Dermatomyositis 5/17/2017
American Urological Association Release: Female Pelvic Health Panel Investigates A Medication For HSDD, Low Serum Testosterone's Association With SUI And Issues Surrounding Transvaginal And Vaginal Mesh 5/15/2017
Veru Healthcare Presents Results From Phase IV Clinical Study Of PREBOOST For Management Of Premature Ejaculation 5/15/2017
Mithra Pharmaceuticals To Initiate PK Study For Estelle 5/12/2017
Janssen Pharmaceutical Release: Real-World Evidence Shows Oral INVOKANA 300 Mg Demonstrates Comparable A1C Reduction And Control To Injectable GLP-1 Receptor Agonists 5/8/2017
Norgine Presents New Post-Hoc Data Analyses Highlighting The Efficacy Of PLENVU For Bowel Cleansing At DDW 5/8/2017
Takeda (TKPYY) Release: New Real-World Analyses Support Effectiveness And Safety Of Entyvio (Vedolizumab) For Ulcerative Colitis And Crohn's Disease 5/8/2017
Gilead (GILD) Release: Multiple Provinces And Territories Demonstrate Leadership In The Treatment Of HIV/AIDS By Providing Access To GENVOYA 5/8/2017
ImmusanT, Inc. Reports Data On Novel Celiac Disease Diagnostic Approach 5/8/2017
Teva (TEVA) Announces Publication Of COPAXONE (Glatiramer Acetate Injection) Pregnancy Data In The International Journal Of MS Care 5/5/2017
Smith & Nephew Inc. (SNN) Release: Collagenase SANTYL Ointment Advances Pressure Ulcers Through The Healing Process Faster, New Study Suggests 5/4/2017
FDA Authorizes Clinical Trial For 22nd Century Group, Inc.’s BRAND B Low Tar-to-Nicotine Ratio Cigarettes 5/1/2017
Janssen R&D Submits Supplemental New Drug Application To U.S. FDA Based On EINSTEIN CHOICE Data, Which Showed Superiority With XARELTO (Rivaroxaban) Versus Aspirin In Reducing Risk Of Recurrent Venous Thromboembolism (VTE), With Low Rates Of Major Bleeding Across Groups 5/1/2017
Synergy Pharma (SGYP) To Highlight New Data For TRULANCE (Plecanatide) At Digestive Disease Week (DDW) 5/1/2017
Entrinsic Health Solutions Announces Positive Top Line Clinical Trial Results In Retrospective Study Of Enterade 4/28/2017
Eisai Inc. (ESALF.PK) Release: Meta-Analysis Of Published Trials Supports The Extrapolation Of Antiepileptic Drug Efficacy Data From Adult To Pediatric Patients With Primary Generalized Tonic-Clonic Seizures 4/27/2017
Britannia Pharmaceuticals Limited: Landmark Apomorphine Study Confirms Its Established Role As A Highly Effective Treatment For Parkinson's Disease Patients Whose Symptoms Cannot Be Controlled On Standard Therapies 4/26/2017
Catabasis (CATB) Announces Favorable Results For Functional Assessments In The Movedmd Trial For Edasalonexent In Duchenne Muscular Dystrophy At American Academy of Neurology 69th Annual Meeting 4/25/2017
Cartiva Announces Completion Of Patient Enrollment And Treatment In Study Of Cartiva Synthetic Cartilage Implant For Pain Associated With Osteoarthritis Of The Thumb 4/25/2017
Paragonix Technologies Inc. Announces Presentation Of The Sherpapak Organ Transport Systems At American Transplant Congress (Chicago, April 29 - May 3, 2017) 4/24/2017
Biogen (BIIB)’s SPINRAZA (Nusinersen) Receives Positive CHMP Opinion For The Treatment Of Spinal Muscular Atrophy 4/24/2017
Novartis AG (NVS) Real-World Data At Aan Confirms Benefit Of Gilenya On Four Key Measures Of Disease Activity In Relapsing MS 4/24/2017
Real-World Observational Study In The U.S. Veterans Affairs System Evaluating Use Of Merck & Co. (MRK)’s ZEPATIER (Elbasvir And Grazoprevir) Shows High Sustained Virologic Response Rates In Patients With Chronic Hepatitis C 4/21/2017
Thermo Fisher Scientific (TMO) Release: Multi-Center Clinical Study Confirms Decreased Levels Of Procalcitonin As An Independent Predictor Of Mortality In Patients With Severe Sepsis And Septic Shock 4/20/2017
NIH Study In The New England Journal of Medicine Shows Novartis AG (NVS) Drug Eltrombopag As First-Line Therapy With Standard Treatment Improves Responses In Severe Aplastic Anemia 4/20/2017
Relypsa (RLYP) Presents Veltassa Phase IV Data Showing Consistent Efficacy And Safety Whether Taken With Or Without Food In Patients With Hyperkalemia 4/20/2017
Kowa Pharmaceuticals America Announces INTREPID Trial Results In The Lancet HIV Showing Superior LDL Cholesterol Reduction With LIVALO (Pitavastatin) Compared With Pravastatin In Adults With HIV And Dyslipidemia 4/19/2017
Egalet Announces FDA Acceptance Of File For Prior Approval Supplement For OXAYDO (Oxycodone Hcl, USP) Tablets C-II 10 Mg And 15 Mg Dosage Strengths 4/18/2017
The Center For The Biology Of Chronic Disease Release: Gene-Eden-VIR/Novirin Vs. Antiviral Drugs, CBCD Reports High Interest In The Comparison Between Natural Treatments And Approved Drugs 4/17/2017
SCIENCE CHINA Life Sciences English Edition Publishes Domestic Type 2 Diabetes Research Findings 4/12/2017
More Than 30 Presentations Of New Investigational Data From Sanofi Genzyme (SNY)’s Multiple Sclerosis Franchise To Be Featured AtAAN 4/11/2017
Galderma Laboratories Presents Results From Phase IV Clinical Studies Of Restylane Refyne And Restylane Defyne At The 15th Aesthetic & Anti-Aging Medicine Annual World Congress 4/7/2017
Switching To Sanofi (SNY)'s Toujeo Showed Significant Reductions In Blood Sugar And Significantly Lower Incidence Of Hypoglycemia In A Real-World Observational Study 4/3/2017
Aequus Pharmaceuticals Announces Positive Results From Second Proof Of Concept Study For Long-Acting Aripiprazole Transdermal Patch 4/3/2017
Cumberland Pharmaceuticals (CPIX) Release: Caldolor Demonstrates Significant Post Surgical Pain Reduction And Decrease In Opioid Use 3/28/2017
AstraZeneca PLC (AZN) Release: New Data Demonstrate RSV Immunoprophylaxis With SYNAGIS (Palivizumab) May Result In Reduced Overall Costs In Preterm Infants Born At 29-32 wGA Who Are Less Than Three Months Of Age 3/28/2017
eClinicalHealth Celebrates 5 Years In Business Supporting Direct-to-Patient Research Models For Clinical Trials 3/27/2017
EMA’s CHMP Recommends Approval Of Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) For The Treatment Of Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma 3/24/2017
Pfizer (PFE) Receives Positive CHMP Opinion For TRUMENBA For Prevention Of Meningococcal Group B Disease 3/24/2017
UCSF Heart Doctor Wary of Amgen (AMGN)-Paid Repatha Study 3/23/2017
Horizon Pharma (HZNP) To Present Data On RAVICTI (Glycerol Phenylbutyrate) Oral Liquid For Urea Cycle Disorder Patients Aged Two Months To Two Years 3/22/2017
Prime Therapeutics Study Finds 97 Percent Of Hepatitis C Patients Cured With Harvoni Treatment 3/21/2017
New Analysis Shows Novartis AG (NVS) Entresto Improves Glycemic Control In Reduced Ejection Fraction Heart Failure Patients With Diabetes 3/20/2017
Boehringer Ingelheim Release: Uninterrupted Pradaxa (Dabigatran Etexilate Mesylate) Showed Less Major Bleeding Than Warfarin In Atrial Fibrillation Patients Undergoing Catheter Ablation 3/20/2017
AstraZeneca PLC (AZN)'s Diabetes Med Cuts Death Rates in Real-World Trial 3/20/2017
Disappointment Hits as Amgen (AMGN)'s Repatha Prevents Heart Attacks, But Not Deaths 3/20/2017
Oncolytics Biotech Inc. (ONC.TO) Enters Into First-In-Class Collaboration With Myeloma UK And Celgene (CELG) Using REOLYSIN In Combination With Imnovid Or Revlimid In Patients With Myeloma 3/16/2017
Horphag Release: Study Shows Pycnogenol Normalizes Cardiovascular Risk Factors In Perimenopausal Women 3/16/2017
Amgen (AMGN) Release: Repatha (Evolocumab) Four-Year Open-Label Follow-Up Study Published In 'JAMA Cardiology' 3/15/2017
Data From BioTime (BTX)’s Opregen Trial In Dry-AMD To Be Presented At Association for Research in Vision & Ophthalmology On May 8 3/15/2017
Elite Pharma (ELI) Initiates Pivotal Bioequivalence Fed Study For Reformulated SequestOx 3/13/2017
Investors Anxiously Await for Amgen (AMGN)'s 27,500-Patient Heart Trial Data This Week 3/13/2017
The OHSU Knight Cancer Institute Release: "The New England Journal of Medicine" Publishes Long-Term Results Of Gleevec® For Patients With Chronic Myeloid Leukemia 3/9/2017
New Head-To-Head Data Shows Significantly Higher Response Rates For Eli Lilly (LLY) 's Taltz (Ixekizumab) Compared To Stelara (Ustekinumab) In Patients With Moderate-To-Severe Plaque Psoriasis 3/6/2017
Celgene (CELG) Release: Oral OTEZLA (Apremilast) Demonstrated Significant Improvement Versus Placebo In Trial Of Patients With Moderate Plaque Psoriasis Who Were Naïve To Systemic And Biologic Therapy 3/6/2017
New Data Demonstrate Sandoz Proposed Biosimilar Adalimumab Has Equivalent Efficacy To Reference Medicine 3/6/2017
Novartis AG (NVS)' Cosentyx Shows Almost All Psoriasis Patients Rapidly Regain Skin Clearance Following A Treatment Pause 3/6/2017
Celgene (CELG) To Present New Data From Clinical Trials On Oral OTEZLA (Apremilast) At American Academy of Dermatology Congress 3/3/2017
Amgen (AMGN) Release: BLINCYTO (blinatumomab) Significantly Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Compared To Chemotherapy 3/2/2017
Amgen (AMGN) Release: Phase III Head-To-Head Trial Showed KYPROLIS (Carfilzomib) Significantly Improved Overall Survival Compared To Velcade (Bortezomib) In Relapsed Or Refractory Multiple Myeloma Patients 2/28/2017
Mederi Therapeutics Inc. Release: Landmark Study: Meta-Analysis Of 28 Studies Shows Stretta Therapy For GERD Consistently And Significantly Improves Outcomes 2/27/2017
Ampio Pharmaceuticals, Inc. (AMPE) Receives Guidance From The FDA And Proposes A Path For Approval For Single-Injection Ampion For The Treatment Of Pain Due To Severe Osteoarthritis Of The Knee 2/27/2017
Real-World Data From Boehringer Ingelheim Show Lower Risk Of Stroke And Major Bleeding For Pradaxa (Dabigatran Etexilate Mesylate) Compared To Warfarin 2/24/2017
GlaxoSmithKline (GSK) Release: Positive Results For Relvar Ellipta Lung Function Study In Patients With Well-Controlled Asthma 2/23/2017
Viriom Reports Positive Findings In Phase IIb Study Of Elpida As Compared To Efavirenz In Combination With TDF/FTC At CROI 2017 2/17/2017
Theratechnologies (TH.TO) Announces Comparative PK Data On The Intramuscular And Intravenous Administration Of The Monoclonal Antibody And Long-Acting Investigational Antiretroviral Ibalizumab 2/16/2017
Sanaria Inc.'s PfSPZ-CVac Vaccine Achieves High Level Protection Against Malaria In Clinical Trial 2/16/2017
Cumberland Pharmaceuticals (CPIX) Release: Caldolor Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics 2/7/2017
AMAG (AMAG) Announces Positive Topline Results From Definitive Pharmacokinetic Study For Makena Subcutaneous Administration 2/2/2017
InSitu Biologics Release: Company Non-Opiate Painkiller, AnestaGel, Found Superior In Preclinical Tests 1/26/2017
scPharmaceuticals Release: Biopharma Announces Start Of SUBQ-HF NHLBI Study With Its Subcutaneous Furosemide Product 1/24/2017
Sorrento (SRNE) Subsidiary, Scilex, Announces Key Endpoints Met In The European Union Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido 1/9/2017
Pfizer (PFE) Announces Positive Top-Line Results From The Comparative REFLECTIONS B538-02 Study For PF-06410293, A Potential Biosimilar To Humira1 (Adalimumab) 1/5/2017
Commercial Patient Data Confirms Success of EnteroMedics (ETRM)' vBloc Therapy In Combination With vBloc Achieve Program In Patients Struggling To Lose Weight 12/15/2016
Pfizer (PFE) And Astellas (ALPMY) Announce Top-Line Results From Phase 4 PLATO Trial Of XTANDI (Enzalutamide) Capsules In Patients With Metastatic Castration-Resistant Prostate Cancer 12/15/2016
Janssen R&D Release: Daratumumab (DARZALEX) Combination Therapy Showed Consistent Clinical Benefit For Previously-Treated Patients With Multiple Myeloma 12/6/2016
Novartis AG (NVS) Data Shows Treatment-Free Remission Rates Are Consistently Above 50% Regardless Of Reason For Switch To Tasigna From Gleevec 12/6/2016
CTI BioPharma Release: PERSIST-2 Phase 3 Study Of Pacritinib Versus Best Available Therapy Shows Encouraging Clinical Activity In High-Risk Patients With Advanced Myelofibrosis In Late-Breaking Session At American Society of Hematology Annual Meeting 12/6/2016
Eisai Inc. (ESALF.PK) Announces New Analyses And Data On Perampanel At American Epilepsy Society Meeting 12/6/2016
Boehringer Ingelheim Release: New Data Show High Adherence Rates With Pradaxa (Dabigatran Etexilate Mesylate) In NVAF Patients 12/5/2016
Sorrento (SRNE) Subsidiary, Scilex Announces Key Endpoints Met In Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido 12/5/2016
Mallinckrodt (MNK) Release: Clinical Pharmacokinetic And Health Economic Data On OFIRMEV (Acetaminophen) Injection Presented At 15th Annual Pain Medicine Meeting Of ASRA 11/18/2016
New Analysis Of Novartis AG (NVS)' Entresto Data Shows Long-Term Benefits On Heart Failure Readmissions And Total Cardiovascular Deaths 11/16/2016
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Lupus 11/15/2016
UCB, Inc. (UCBJF.PK) Release: The Lancet Publishes First Head-To-Head Study Of CIMZIA (Certolizumab Pegol) And Humira (Adalimumab) In Bio-Naïve Rheumatoid Arthritis Patients 11/15/2016
Eli Lilly (LLY) Release: Jardiance (Empagliflozin) Consistently Reduced The Risk Of Cardiovascular Death In Adults With Type 2 Diabetes Regardless Of The Type Of Cardiovascular Disease At Baseline 11/14/2016
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Rheumatoid Arthritis 11/14/2016
Eli Lilly (LLY) Release: Baricitinib Demonstrates Early Response Compared To Placebo And Significant Improvement Compared To Adalimumab In Patient-Reported Outcomes 11/14/2016
Horizon Pharma (HZNP) Presents Data On KRYSTEXXA (Pegloticase) For The Management Of Refractory Chronic Gout At The 2016 ACR/ARHP Annual Meeting 11/14/2016
Janssen Biotech (JNJ) Release: Two Studies Reveal Differences In Real-World Treatment Patterns In Rheumatoid Arthritis Patients Taking REMICAD (infliximab) Compared To CT-P13 (infliximab biosimilar) 11/14/2016
Eli Lilly (LLY) Release: New Analyses Of Phase 3 Trials Show Improvements In Rheumatoid Arthritis Symptoms Following Treatment With Baricitinib Across Diverse Population Of Patients 11/14/2016
Bayer (BAY) Release: 20+ Years Of Safety Data, Clinical Trials & Real-World Use Confirm Positive Benefit/Risk Profile Of ALEVE 11/14/2016
Bristol-Myers Squibb (BMY) Showcases Rheumatoid Arthritis And Immunoscience Commitment With Depth Of Research At 2016 American College of Rheumatology And Association Of Rheumatology Health Professionals Annual Meeting 11/14/2016
Sunovion Announces Positive Clinical Study Results For Latuda (Lurasidone HCL) In Adolescents With Schizophrenia 10/27/2016
Imprimis (immy)' Dropless Therapy Shows Significant Advantages In A Large Peer-Reviewed Study 10/25/2016
Janssen Pharmaceutical Release: Two New Real-World Studies Confirm Positive Efficacy And Safety Profile Of XARELTO (Rivaroxaban) In Treating And Preventing Blood Clots 10/24/2016
Boehringer Ingelheim Release: New Real-World Data Show Pradaxa (Dabigatran Etexilate Mesylate) Treatment Resulted In Less Use Of All-Cause Healthcare Resources Than Warfarin Treatment 10/21/2016
Takeda (TKPYY)'s Vedolizumab Demonstrated Robust Clinical Effectiveness And Safety In Inflammatory Bowel Disease In More Than 50 Real-World Studies 10/17/2016
Amgen (AMGN) Release: New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin 10/10/2016
Ampio Pharmaceuticals, Inc. (AMPE) Announces Accepted Publication Of The Clinical Trial Results Of Its Oral Drug, Optina, Treatment Of Diabetic Macular Edema 10/4/2016
PTC Therapeutics (PTCT) Release: New Research Validates Translarna's (Ataluren) Mechanism Of Action To Promote Readthrough Of Nonsense Mutations And Produce Full-Length Functional Protein 10/4/2016
AstraZeneca PLC (AZN) Suffers Another Blow After Blood-Thinning Drug Flunks Trial 10/4/2016
Novartis AG (NVS) Late-Breaking Data Show Cosentyx Continues To Deliver High Skin Clearance For Majority Of Psoriasis Patients At Four Years 10/3/2016
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: Additional Interim Data Supporting Long-Term Use Of Vedolizumab In Patients With Ulcerative Colitis And Crohn's Disease Published In Journal Of Crohn's And Colitis 9/29/2016
Lubricin Release: Data Demonstrates Significant Improvement In Multiple Signs And Symptoms Of Dry Eye Disease Compared To Sodium Hyaluronate 9/20/2016
Important New Analysis Shows That Novartis Pharmaceutical Corporation (NVS)' Entresto Is Associated With Higher Relative Health-Related Quality Of Life Scores Among HFrEF Patients 9/19/2016
Roche (RHHBY) Says New MS Drug Works Better Than Merck & Co. (MRK)'s Rebif 9/19/2016
DelMar Pharma Presents Data Supporting The Potential Of VAL-083 As A New Treatment For Ovarian Cancer At The 11th Biennial Ovarian Cancer Research Symposium 9/13/2016
vBloc Institute Demonstrates Positive Clinical Success In Patients Struggling With Weight Loss As Compared To Pivotal FDA Trial With EnteroMedics (ETRM) VBloc Therapy In Combination With VBloc Achieve Program 9/13/2016
Egalet Announces OXAYDO Demonstrates Bioequivalence At 15 Mg Dose 9/12/2016
Kaleo Presents Studies At PAINWeek 2016 Comparing Naloxone Intramuscular Injection And Naloxone Intranasal Administration 9/8/2016
Raptor (RPTP) Presents Results From Meta-Analysis Demonstrating Efficacy Of QUINSAIR Comparable To Other Approved, Inhaled Antibiotics In Cystic Fibrosis Patients 9/7/2016
Boehringer Ingelheim Relelase: New Long-Term Data Demonstrates Continued Safety And Beneficial Effect Of Ofev (Nintedanib) For Patients With IPF 9/7/2016
Boehringer Ingelheim Release: New Long-Term Data Demonstrates Continued Safety And Beneficial Effect Of OFEV (Nintedanib) For Patients With IPF 9/7/2016
Boehringer Ingelheim Release: Tiotropium RESPIMAT Improved Lung Function With Safety Comparable To Placebo In Children With Asthma 9/6/2016
Vectura (VEC.L) Release: New Findings Confirm Ultibro Breezhaler Consistently More Effective Than Seretide In Reducing COPD Flare-Ups Across Different Patient Groups 9/6/2016
AstraZeneca PLC (AZN)'s Long-Acting Asthma Drug Symbicort Safe in Two Trials 9/1/2016
Seqirus Presents Analysis Reinforcing The Safety And Immunogenicity Profiles Of Its MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine In Adults 65 Years And Older 8/29/2016
Amgen (AMGN) Announces Positive Top-Line Results From Phase 3 Study Of Prolia (Denosumab) In Patients Receiving Glucocorticoid Therapy 8/29/2016
Amgen (AMGN) Release: New Repatha (evolocumab) Analyses Show Efficacy And Safety Across Risk Groups In Results Presented At European Society of Cardiology Congress 2016 8/29/2016
Merck & Co. (MRK)'s Keytruda May Have an Edge Over Bristol-Myers Squibb (BMY)'s Opdivo for Cancer Doctors 8/26/2016
Armetheon Announces Positive Results Of Pharmacokinetics Study Of Tecarfarin Versus Warfarin 8/25/2016
Sunovion Pharmaceuticals Inc. Announces Publication Of Data Evaluating Dose Escalation Of Latuda (Lurasidone HCL) In The Treatment Of Schizophrenia 8/8/2016
Novo Nordisk A/S (NVO)'s Blockbuster Diabetes Med Victoza Does Not Help Severe Heart Failure 8/4/2016
Imprimis (immy) Release: Peer-Reviewed Study Of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared To Drops 7/22/2016
Amgen (AMGN) And Allergan (AGN) Biosimilar Found as Effective as Genentech (RHHBY)'s Herceptin 7/21/2016
Pfizer (PFE) Receives WHO Prequalification For Multi-Dose Vial Presentation Of Prevenar 13 7/19/2016
Mallinckrodt (MNK) Warned Over Missing Study About Child Opioids Use 7/8/2016
FDA Panel Narrowly Backs Cardiovascular Claims for Boehringer Ingelheim, Eli Lilly (LLY)'s Jardiance 6/29/2016
Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Analysis Of INPULSIS Trials Demonstrates Efficacy Of OFEV (Nintedanib) Across A Range Of IPF Patients Using Broader Diagnostic Criteria 6/27/2016
Roche (RHHBY) CEO 'Sleeping Much Better' Following Positive News About Three New Drugs 6/23/2016
FDA Bestows Incyte (INCY)'s Ruxolitinib with Breakthrough Tag for Graft-Versus-Host Disease 6/23/2016
Kowa Pharmaceuticals America Release: New Data Demonstrate Pitavastatin More Effective Than Pravastatin In Improving Inflammatory And Immune Activation Markers In HIV-Infected Patients 6/21/2016
Pernix (PTX) Announces Positive Phase IV Results Of Silenor Vs. Zolpidem Head-To-Head Arousability Study 6/16/2016
Merck & Co. (MRK) Release: Systematic Review Of 58 Publications Of Real-World Use Of GARDASIL Presented At EUROGIN Congress 6/16/2016
Novo Nordisk A/S (NVO) Investors Disappointed as Top Selling Drug Victoza Didn't Do as Well as Expected 6/14/2016
Boehringer Ingelheim And Eli Lilly (LLY) Release: Jardiance (Empagliflozin) Significantly Reduced The Risk Of Progressive Kidney Disease In Adults With Type 2 Diabetes With Established Cardiovascular Disease 6/14/2016
Boehringer Ingelheim And Eli Lilly (LLY) Release: New Study Results Show Trajenta (Linagliptin) Reduces Blood Sugar In Adults With Type 2 Diabetes At Risk For Kidney Impairment 6/13/2016
AstraZeneca PLC (AZN) Presents New Data From Multiple Studies On The Effect Of BYDUREON On Glucose Fluctuations In Patients With Type 2 Diabetes 6/13/2016
New Data Presented At The Annual European Congress Of Rheumatology (EULAR 2016) Demonstrate Safety And Efficacy Of Biogen (BIIB)’s Anti-TNF Biosimilars Portfolio 6/9/2016